Evidence map›Paper›PMID 20070531›Full record

ArticleMolecular microbiology2010

Utilization of variably spaced promoter-like elements by the bacterial RNA polymerase holoenzyme during early elongation.

Pukhrambam Grihanjali Devi, Elizabeth A Campbell, Seth A Darst, Bryce E Nickels

Abstract read
In one paragraph

Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Pukhrambam Grihanjali DeviDepartment of Genetics and Waksman Institute, Rutgers University, Piscataway, NJ 08854, USA.
Elizabeth A Campbell
Seth A Darst
Bryce E Nickels

Funding

E COLI RNA POLYMERASE SUBUNIT--STRUCTURE/FUNCTIONR01GM053759 · NIGMS · ROCKEFELLER UNIVERSITY · PI DARST, SETH A. · 1996 to 2015
$6.9M
NIGMS NIH HHS GM053759NIGMS NIH HHS R01 GM053759
6 · The paper itself

Abstract

The bacterial RNA polymeras holoenzyme consists of a catalytic core enzyme in complex with a sigma factor that is required for promoter-specific transcription initiation. During initiation, members of the sigma(70) family of sigma factors contact two conserved promoter elements, the -10 and -35 elements, which are separated by approximately 17 base pairs (bp). sigma(70) family members contain four flexibly linked domains. Two of these domains, sigma(2) and sigma(4), contain determinants for interactions with the promoter -10 and -35 elements respectively. sigma(2) and sigma(4) also contain core-binding determinants. When bound to core the inter-domain distance between sigma(2) and sigma(4) matches the distance between promoter elements separated by approximately 17 bp. Prior work indicates that during early elongation the nascent RNA-assisted displacement of sigma(4) from core can enable the holoenzyme to adopt a configuration in which sigma(2) and sigma(4) are bound to 'promoter-like' DNA elements separated by a single base pair. Here we demonstrate that holoenzyme can also adopt configurations in which sigma(2) and sigma(4) are bound to 'promoter-like' DNA elements separated by 0, 2 or 3 bp. Thus, our findings suggest that displacement of sigma(4) from core enables the RNA polymerase holoenzyme to adopt a broad range of 'elongation-specific' configurations.

Indexed as

Promoter Regions, GeneticTranscription, GeneticBacteriaDNA-Directed RNA PolymerasesHoloenzymesRegulatory Sequences, Nucleic AcidRNA, BacterialSigma FactorViral ProteinsDNA-Directed RNA PolymerasesHoloenzymesQ protein, Bacteriophage lambdaRNA, BacterialRNA polymerase sigma 70Sigma FactorViral Proteins

Identifiers

PMID20070531
PMCPMC3274365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.